Miso Clinic · Clinical column

Density lifting in Daegu — everything to know before treatment, in one place

Miso Clinic’s writing on Density is spread across several pages: the product reference, comparisons, shot counts, side effects and recovery. This column is the first page to read if you are looking into Density in Daegu: each question gets a short answer and a link to the detailed page.

Clinical column About 5 min September 2026 Miso Clinic, Daegu · Dr. Lee Chi-Hak, Medical Director

The short answer

Density is a radiofrequency (RF) lifting device made by Jeisys Medical that delivers monopolar and then bipolar RF in sequence, treating different depths one after the other. Miso Clinic considers Density first for early-to-moderate sagging, where the jawline has blurred and the cheeks have dropped, and not first when the main problem is lost volume or thin, dull skin. The only human data on Density is one case series of 16 Japanese adults · one session · 24 weeks with no control group (tightening 0.82 mm, pain 1.4/5, no burns reported). Density results are judged two to three months after treatment. Miso Clinic is in Jung-gu, Daegu, at Exit 1 of Kyungpook National University Hospital Station.

What kind of lifting device is Density? At a glance

Density at a glance
ItemDetails
Density manufacturerJeisys Medical (South Korea)
Density deliveryMonopolar → bipolar RF in sequence (manufacturer: patented sequential heating)
Density safety featuresFive-level gas cooling · RIC automatic impedance adjustment · real-time skin temperature display
Density tipsFour: ALPHA · Eye · Face · Body (guaranteed shots 600 · 600 · 1,000 · 600)
Density approval in KoreaMedical device approved by Korea’s Ministry of Food and Drug Safety (MFDS, the national regulator of medicines and medical devices) — we could not verify the approval number in the original record
Density human dataOne case series · 16 people · one session · 24 weeks, no control group
What Density treatsSagging · jawline · firmness — the dermis and the structure beneath it
What Density does not treatLost volume, pigmentation, removal of excess skin

We found no comparative trial showing that Density’s sequential delivery gives better results than a single mode. The sequence explains how Density was designed; it is not evidence of superiority.

Which faces does Density suit, and which does it not?

Density — when we consider it first and when we do not (clinical judgement)
This situationDensity decisionWhy
Jawline blurred, cheeks feel lowerConsider Density firstSagging is what RF treats
Thicker skin with deeper saggingConsider Density firstDensity is designed to treat deep and shallow layers in sequence
Texture and density already treated with injectables, sagging remainsConsider DensityDensity works on a different layer
Hollow cheeks or templesDensity not recommendedHeat does not create volume
Thin, dull skin is the main problemAnother category before DensitySkin boosters · collagen boosters
Pacemaker, defibrillator or other implanted electrical deviceDensity generally avoidedRF uses electrical current
Skin so lax it foldsDensity not recommendedBeyond the range of non-surgical devices

How Miso Clinic divides cases between Density and other devices is set out in Density vs XERF in Daegu and choosing between Oligio Kiss, Density and XERF.

How far have Density results been confirmed?

Density human data (J Cosmet Dermatol 2025)
ItemDetails
Density study population and design16 Japanese adults (1 man · 15 women, mean age 49.4) · one session · 24 weeks · no control group · single author
Density treatment doseAbout 500–600 shots in one session
Density resultsTightening 0.82 mm, lower-face thickness −0.89 mm, GAIS improved in 15 of 16
Density pain and adverse events1.4/5; no burns, persistent erythema or scarring reported

The Density paper’s conclusion uses the phrase “clinically proven”, but Miso Clinic does not repeat it, because a 16-person case series without a control group cannot carry that claim. Why the missing control group matters is explained in why some reviews say Density and XERF did nothing.

Density pain, shot count, recovery, duration and side effects

  • Density pain — a hot sensation rises briefly and fades, over and over. Areas close to bone or with thin skin are more sensitive, and numbing cream is used depending on the area. Heat you cannot bear during Density is a safety signal to tell us about, not something to endure.
  • Density shot count — Density shots are a fixed allocation sealed into each tip, so the count is set by the area and number of regions. No human study has randomly compared 300 and 600 Density shots (Density 300 shots versus 600).
  • Density recovery — the tight feeling right after Density is immediate contraction plus swelling; results are judged at two to three months (the first three months after Density or XERF).
  • How long Density lasts — the Density data follow people for only 24 weeks, so we do not promise a number of months (how long Density and XERF last).
  • Density side effects — burns appear within 72 hours and fat atrophy at one to four months, so there are two periods to watch (Density and XERF side effects and burns).

Density in Daegu summary — what is established and what is not

What is established about Density

  • Density delivers monopolar → bipolar RF in sequence, with gas cooling, RIC and temperature display
  • One human Density study: 16 people · 24 weeks · no control group, no burns reported
  • Density is not the first choice for lost volume or thin skin

What we could not find for Density

  • A controlled Density study, or a direct comparison with another device
  • Density duration beyond 24 weeks
  • The Density MFDS approval number in the original record, or a US FDA listing

Density in Daegu: frequently asked questions

What kind of lifting is Density?

Density is a radiofrequency lifting device made by Jeisys Medical that delivers monopolar and then bipolar RF in sequence to heat the dermis and the structure beneath it. Density aims at sagging, jawline and firmness; it does not add volume.

Have Density results been proven?

The human data on Density is one case series of 16 people followed for 24 weeks, reporting 0.82 mm of tightening and improvement in 15 of 16, with no control group. For that reason Miso Clinic does not describe Density as “clinically proven”.

Does Density hurt?

Density produces short, repeated waves of heat. The Density study reported a mean pain score of 1.4/5, but how it feels varies with area and settings, and areas close to bone are more sensitive. Numbing cream is used depending on the area.

How many Density shots do I need?

The Density shot count is set by the area and the number of regions treated. The Density study used about 500–600 shots in one session, but no human study has randomly compared shot counts, so there is no basis for saying more Density shots are better.

How long do Density results last?

The Density data follow people for 24 weeks. For RF lifting in general a peak at four to six months has been reported, but those are not Density data, so the timing of the next Density session is decided from the state of the face.

Can I wear make-up and go to work on the day of Density?

Non-invasive RF such as Density does not break the epidermis, and clinical trials advised immediate return to normal activity and usual cosmetics. Redness after Density can last from a few hours to a day.

Should I choose Density or XERF?

No study has compared Density and XERF directly in people. Miso Clinic starts from the face: Density first when the skin is thicker and the sagging deeper, XERF first when avoiding anaesthesia and returning to normal the same day matter most (clinical judgement).

How is Density different from Thermage?

Density and Thermage both belong to the 6.78 MHz monopolar RF family, but Density adds bipolar RF in sequence, and the body of evidence for Thermage is far larger. No direct comparison study exists, and Miso Clinic does not have Thermage.

Where is Miso Clinic in Daegu, where Density is available?

Miso Clinic in Daegu, which offers Density, is at 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, at Exit 1 of Kyungpook National University Hospital Station. Phone +82-53-428-2700; open weekdays 11:00–19:00 and Saturdays 10:00–16:00 (no lunch break), closed Sundays and public holidays.

Read next

Product pages

The device itself is covered in the Density product reference. Other devices at the same clinic: XERF · Oligio Kiss

Who wrote this

Written and reviewed by Lee Chi-Hak, MD, medical director of Miso Clinic in Daegu, South Korea. Every study cited above is given together with its design, its size and the limitations the authors themselves recorded, and where we could not find data, we have said that we could not find any.

Miso Clinic
Medical directorLee Chi-Hak, MD
Address4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, South Korea · Exit 1, Kyungpook National University Hospital Station
Phone+82-53-428-2700
HoursWeekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays
ColumnsAll clinical columns
Reference libraryAll booster and device references

References

  1. Density human data — Oku K, J Cosmet Dermatol 2025;24(10):e70504, PMID 41090512. The paper names DENSITY (Jeisys Medical) in the main text. 16 Japanese adults (1 man · 15 women, mean age 49.4 ± 6.1) · one session of about 500–600 shots · 24 weeks · no control group · single author. Tightening 0.82 mm, lower-face thickness −0.89 mm, GAIS improved in 15 of 16, pain 1.4/5, no burns, persistent erythema or scarring reported. The abstract (0.82 ± 0.36) and the main text (± 0.34) give different values.
  2. Density specifications — Jeisys Medical published material: sequential monopolar → bipolar delivery, up to 400 W, RIC automatic impedance adjustment, five-level gas cooling, real-time skin temperature display, tips ALPHA 600 · Eye 600 · Face 1,000 · Body 600 shots (guaranteed shot counts). Medical device approved by Korea’s MFDS; approval number not verified in the original record.
  3. Thermage — Solta Medical, 6.78 MHz monopolar, device registered with the US FDA. There are many publications, but most are uncontrolled observational studies or physician surveys, and a 2020 international Delphi consensus noted that device-specific guidance is lacking. No study has compared it directly with Density or XERF. Miso Clinic does not have Thermage or Ulthera.
  4. Timeline of RF resultsCosmetics 2024;11(3):71 (20 Korean women: clinical assessment not significant at 4 weeks · significant at 12 and 24 weeks; device-measured elasticity from 4 weeks) · Weiss 2026 (84.6% at 30 days → 92.3% at 90 days) · Fitzpatrick 2003 and Edwards AF et al., Dermatol Surg 2013;39:104–110 (peak at 4–6 months). None has a control group.
  5. Timing and frequency of RF adverse events (older device) — Fitzpatrick R et al., Lasers Surg Med 2003;33:232–242 (86 subjects): blistering 2.3% immediately · 3.8% within 72 hours; second-degree burns in 21 of 5,858 treatments (0.36%) — figures for the 2002 high-energy single-pass technique, not a current incidence.
  6. Fat atrophy — Narins RS et al., Dermatol Surg 2006;32:115–124. Appears at 1–4 months (mean 2 months), about 4 per 10,000 treatments. Notes that heavy anaesthesia blocks pain feedback.
  7. Medical advertising law — Korea’s Medical Service Act, Article 56(2). It prohibits advertising through treatment testimonials, comparison with other medical institutions, superlative claims and similar.

Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.

← Clinical columns · Reference library · Miso Clinic home

한국어 · English · 日本語